|Day's Range||181.06 - 182.86|
|52 Week Range||139.07 - 182.86|
|PE Ratio (TTM)||33.23|
|Dividend & Yield||0.60 (0.33%)|
|1y Target Est||N/A|
Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.
Strong focus on product launch and emerging market expansion should drive Thermo Fisher (TMO) toward an earnings beat in Q2.
Rating Action: Moody's assigns Baa2 to Thermo Fisher's EUR bonds; outlook stable. Global Credit Research- 18 Jul 2017. New York, July 18, 2017-- Moody's Investors Service assigned Baa2 ratings to four ...